Cipla
Nick Spinoso is a Senior Manager in Contracts and Pricing at Cipla since January 2024. Prior experience includes serving as Manager of Contracts and Pricing at Pharmaceutical Associates Inc. from August 2021 to December 2023, and as Senior Analyst and Analyst in the same field at Par Pharmaceutical from September 2018 to August 2021. Nick began a career in pricing and contracts as a Pricing/Contracts Analyst at Unichem Pharmaceuticals (USA), Inc. from June 2017 to September 2018 and held an internship as a Returns Analyst at Valeant Pharmaceuticals in 2016. Earlier roles include working as a Professional Server at Baron Staffing LLC and as a Camp Counselor for the Borough of Paramus. Nick holds a Master of Business Administration from Ramapo College of New Jersey and a Bachelor’s of Science Degree in Finance with a minor in International Business from the University of Delaware.
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.